AIDS Weekly articles from August 1992

AIDS Weekly archives from August 1992

Open meeting planned on AIDS surveillance case definition expansion. (U.S. Centers for Disease Control)
August 31, 1992... U.S. CDC The U.S. Centers for Disease Control (CDC) says tests are already being used in many hospitals that would allow federal health officials to broaden the definition of AIDS to include another 160,000 people. A study...

AIDS Institute tests new drug to kill HIV-infected cells. (CD4-PE40, recombinant fusion toxin) (University of California, Los Angeles)
August 31, 1992... University of California, Los Angeles A new chemotherapeutic agent, CD4-PE40, is being tested at the University of California, Los Angeles, (UCLA) AIDS Institute and three other centers in the U.S. to evaluate its safety and tolerance...

Enzyme-based antiseptic reportedly kills HIV on contact. (Exact, based on myeloperoxidase and eosinophil peroxidase) (ExOxEmis Inc.)
August 31, 1992... ExOxEmis Inc. ExOxEmis, Little Rock, Arkansas, reports to have developed two enzymes, Myeloperoxidase (MPO) and Eosinophil Peroxidase (EPO), trade named Exact, which kill HIV on contact. Jackson T. Stephens Jr., chairman of...

Substance that protects cells against HIV in vitro discovered. (prostratin) (Samoa)
August 31, 1992... Samoa In the rain forests of a western Samoan island, a Brigham Young University (BYU), Salt Lake City, Utah, professor has found a tree containing a substance, prostratin, that protects cells against HIV in vitro. "Everything we...

FDA-approved 10-minute HIV test available. (Murex SUDS HIV-1 Test) (Michigan)
August 31, 1992... Michigan A 10-minute HIV-1 test will be made available for the first time for use in private physician offices and other medical facilities. The HIV test, which has been fully approved by the U.S. Food and Drug Administration...

Seven-minute HIV test approved. (SeroCard HIV-I) (Mexico)
August 31, 1992... Mexico Disease Detection International Inc., Irvine, California, announced that the company's seven-minute, whole blood, HIV test has been approved for sale and manufacturing in Mexico by the Secretary of Health. The company's...

HIV-positive test results must be reported to health officials beginning January 1993. (regulation includes partner notification) (Georgia)
August 31, 1992... Georgia Physicians, hospitals and clinics in Georgia performing tests for HIV must begin January 1, 1993, to report to health officials the names and addresses of those who test positive. The state Department of Human Resources...

Court denies request to dismiss lawsuit challenging mandatory HIV testing of Job Corps applicants. (Washington, D.C.)
August 31, 1992... Washington, D.C. A federal judge in Washington, D.C., rejected a motion by the federal government to dismiss a legal challenge to the mandatory HIV testing policy of the U.S. Job Corps. In an opinion filed August 10, 1992, Federal...

Availability of HIV Collaborative Prevention Grants announced. (U.S. Conference of Mayors)
August 31, 1992... U.S. Conference of Mayors The U.S. Conference of Mayors and its affiliate, the U.S. Conference of Local Health Officers, released a Request for Proposals (RFP) for its new grant initiative to strengthen local capacity to carry out...

Survey reports PWAs have financial difficulties and are often subject to violence. (National Association of People with AIDS)
August 31, 1992... National Association of People with AIDS Americans who are HIV positive or living with AIDS have significant difficulty in managing the activities of daily life and obtaining and paying for medical care. Respondents to a...

Officials warn of rising AIDS-related investment scheme. (North American Securities Administrators Association)
August 31, 1992... The North American Securities Administrators Association (NASSA) is warning AIDS patients about selling their life insurance benefits cheaply to get cash for medical bills and living expenses. NASSA is the national organization of the...

AIDS education intensifies. (Nigeria)
August 31, 1992... Through the nation's 589 local government councils, Nigerian authorities have intensified their efforts to prevent the spread of HIV. According to the World Health Organization (WHO), there are over 500,000 AIDS cases worldwide. Africa...

Research career development in Mycobacterium tuberculosis. (National Institute of Allergy and Infectious Diseases program announcement) (Research Report)
August 31, 1992... AUTHORS: PA Number: PA-92-96. National Institute of Allergy and Infectious Diseases. "Purpose: The Department of Health and Human Services (DHHS) National Action Plan to Combat Multidrug-Resistant Tuberculosis (April 1992) has...

Specificity of antibodies produced against native or desialylated recombinant HIV-1 gp160. (Research Report)
August 31, 1992... AUTHORS: A. Benjouad, J. Gluckman, H. Rochat, L. Montagnier and E. Bahraoui. CNRS URA 1455, Marseille; CNRS URA 1463, Hopital de la Pitie-Salpetriere, Paris; Unite d'Oncologie Virale, Institut Pasteur, Paris. According to an abstract...

Vaccine-therapy with gp160: effect on human anti-gp120 antibody spectrotype. (Research Report)
August 31, 1992... AUTHORS: R. Biselli, L. Loomis, V. Del Bono, D. Burke, R. Redfield and D. Birx. Department of Retroviral Research, Walter Reed Army Institute of Research; Retroviral Research Laboratory, Henry M. Jackson Foundation; Rockville, Maryland....

Recombinant human erythropoietin (r-HuEPO) treatment IND protocol for the anemia of AIDS - overall results and AZT subgroup analysis. (Research Report)
August 31, 1992... AUTHORS: J. Phair and R. Abels. Northwestern University Medical School, Chicago, Illinois; R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey. According to an abstract submitted by the authors to the VIII...

Potential of selectively deglycosylated HIV-1 gp120 as a more effective vaccine antigen. (Research Report)
August 31, 1992... AUTHORS: T. Lee, C. Lee, W. Lee, Y. Cheng, H. Lin and M. Essex. Harvard School of Public Health, Boston, Massachusetts. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam,...

Significance of cell antigens in SIV vaccines. (simian immunodeficiency virus) (Research Report)
August 31, 1992... AUTHORS: J. Stott, K. Mills, W. Chan, M. Page, L. Taffs and P. Kitchin. National Institute for Biological Standards and Control, Potters Bar, Herts, Great Britain. According to an abstract submitted by the authors to the VIII...

Determinants of antibody response in volunteers primed with vac-env and boosted with RGP160. (recombinant vaccinia, recombinant glycoprotein 160) (Research Report)
August 31, 1992... AUTHORS: B. Graham, R. Belshe, M. Clements, R. Dolin, L. Corey, T. Matthews, J. Esterlitz, P. Fast and the NIAID AIDS Vaccine Clinical Trials Network, United States. According to an abstract submitted by the authors to the VIII...

Characterization of the natural antibody response to the hypervariable neutralization domain of HIV-1. (Research Report)
August 31, 1992... AUTHORS: G. Zwart, T. Wolfs, L. van der Hoek, M. Valk and K. Goudsmit. Human Retrovirus Laboratory, AMC, Amsterdam, The Netherlands. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held...

Vaccine protection from SIV infected cell challenge is MHC class I related. (simian immunodeficiency virus; major histocompatibility complex) (Research Report)
August 31, 1992... AUTHORS: J. Heeney, R. Bontrop, C. Van Els, P. De Vries, M. Jonker and A. Osterhaus. Department of Chronic and Infectious Diseases, ITRI-TNO, Rijswijk; National Institute of Public Health and Environmental Protection, Bilthoven; The...

A Phase I study of recombinant CD4-Pseudomonas exotoxin (CD4-PE40) in HIV-infected individuals. (Research Report)
August 31, 1992... AUTHORS: R. Davey Jr., C. Boenning, D. Batts, R. Walker, M. Plis, J. Falloon, J. Kovacs, H. Masur, J. Metcalf, M. Smolskis, S. Cox, L. Wathen and H. Lane. National Institutes of Health, Bethesda, Maryland; Upjohn Company, Kalamazoo,...

The safety, pharmacokinetics and antiviral activity of N-acetylcysteine in HIV-infected individuals. (Research Report)
August 31, 1992... AUTHORS: R. Walker, H. Lane, C. Boenning, M. Plis, J. Kovas, J. Falloon, R. Davey, H. Sussman, L. Gabel, R. Correa-Coronas, H. Masur and A. Fauci. National Institutes of Health, Bethesda, Maryland; Stanford University, Palo Alto,...

Human infection by genetically diverse SIV(sm)-related HIV-2 in West Africa. (Periodical Report)
August 31, 1992... SOURCE: Nature, August 6, 1992;358(6386):495-499. "HIV-2 in man and SIV in mangabeys and captive macaques represent members of a single, albeit genetically diverse, group of viruses," suggest researchers who studied HIV-2 sequences...

Vaccination of vaccinia-naive adults with human immunodeficiency virus type-1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. (Periodical Report)
August 31, 1992... SOURCE: Journal of Infectious Diseases, August 1992;166(2):244-252. An experimental HIV-1 vaccine based on recombinant HIV-1 gp160 glycoprotein can be administered safely to healthy adults, who subsequently exhibit both humoral and...

Herpes simplex virus type-2 infection, syphilis and hepatitis-B virus infection in Haitian women with human immunodeficiency virus type-1 and human T-lymphotropic virus type-I infections. (Periodical Report)
August 31, 1992... SOURCE: Journal of Infectious Diseases, August 1992;166(2):418-420. The recurrent disruptions of genital mucous membranes by herpes simplex type 2 (HSV-2) predispose women for sexual acquisition of HIV-1 infection, a Johns Hopkins...

Mycoplasma-penetrans Sp-Nov, from the urogenital tract of patients with AIDS. (Periodical Report)
August 31, 1992... SOURCE: International Journal of Systematic Bacteriology, July 1992;42(3):357-364. Armed Forces Institute of Pathology researcher Shyh-Ching Lo and colleagues report the characterization of a novel mycoplasma isolated from the urine...

Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients - United States, 1990. (Periodical Report)
August 31, 1992... SOURCE: Morbidity and Mortality Weekly Report, August 21, 1992. "The pathogenesis of disease caused by human immunodeficiency virus (HIV) is largely attributable to the decrease in T-lymphocytes bearing the CD4 cell-surface molecule...

Jury still out on etiology of HIV-negative CD4 deficiency. (idiopathic CD4 T-lymphocytopenia) (U.S. Centers for Disease Control)
August 24, 1992... U.S. CDC Amid fears that a new immunodeficiency virus threatens the nation, a panel of experts convened by the U.S. Centers for Disease Control (CDC) to discuss the perceived crisis found cause for concern but not alarm. Their...

WHO to hold global meeting on HIV-negative immune deficiency. (World Health Organization, Geneva, Switzerland)
August 24, 1992... Geneva, Switzerland The World Health Organization (WHO) will convene an international meeting to discuss the global response to severe immune deficiency in people without HIV infection, a spokesperson said. Benjamin Nkowane, chief...

Immunosuppression among people not infected with HIV investigated. (U.S. National Institutes of Health/U.S. Centers for Disease Control)
August 24, 1992... U.S. NIH / U.S. CDC The U.S. National Institutes of Health (NIH) is making its network of research resources immediately available for clinical and laboratory investigations of individuals with severe immunosuppression similar to that...

U.S. blood supply safe from AIDS-like illness, officials say. (American Association of Blood Banks/American Red Cross)
August 24, 1992... There is no evidence that a mysterious AIDS-like illness is being spread through blood transfusions, officials said August 18, 1992. "The evidence we have right now is the blood supply is as safe as it's ever been," said Dr. Peter...

Routine HIV testing in hospitals suggested. (U.S. Centers for Disease Control)
August 24, 1992... Government scientists said routine HIV testing at hospitals could identify up to 110,000 people a year who are infected with the virus but don't know it. The goal of finding such people is to offer them early treatment, which can delay...

Insurance firm, citing tainted-blood scandal, renounces contracts. (Union des Assurances de Paris) (France)
August 24, 1992... France's largest insurance company said it was canceling the policies of 25 transfusion centers because of revelations from the trial of four doctors charged with allowing the sale of HIV-tainted blood. Michel Garretta, former director...

New receptor for HIV found in colon cells. (Dr. Jacques Fantini's research on galactosyl ceramide) (France)
August 24, 1992... A new type of receptor for HIV has been discovered in human colon cells, Dr. Jacques Fantini and his colleagues report in the August 1992 issue of the Journal of Virology. "By finding this receptor, we now have evidence that the virus...

HIV-2 found less deadly than HIV-1. (Harvard AIDS Institute)
August 24, 1992... People infected with HIV-1 are perhaps 10 times more likely to develop AIDS than those infected with HIV-2, according to researchers at Harvard University, Cambridge, Massachusetts, and the University of Dakar, Senegal. In...

Study suggests HIV hitchhikes on blood cell. (dendritic cells) (Rockefeller University)
August 24, 1992... In vitro studies at Rockefeller University New York, New York suggest that HIV is carried to its target cells by a type of blood cell that is never infected itself. The study, published July 17, 1992, in the journal Science, said HIV...

Researchers report technique keeps HIV dormant. (Thomas Jefferson University)
August 24, 1992... A laboratory technique that keeps HIV dormant inside some blood cells might lead to a way to prevent the disease from overwhelming a person's immune system, researchers reported. In the July 15, 1992, issue of the Proceedings of the...

Medical center researchers discover how HIV invades cells. (University of Nebraska)
August 24, 1992... Researchers at the University of Nebraska (NU) Medical Center, Omaha, Nebraska, say they have discovered how HIV invades the nucleus of a cell to spread. The discovery may point to another way to attack HIV, said researcher Mario...

Scientists find genetic cause for TB drug resistance. (England)
August 24, 1992... Scientists said they have figured out how some tuberculosis (TB) bacteria resist a standard drug, a finding that may lead to better treatment. The researchers found that some TB bacteria lack a certain gene that would make them respond...

AIDS death toll for New York may reach 100,000 in six years. (New York Health Department)
August 24, 1992... Health officials are predicting New York's death toll from AIDS could reach 100,000 by the end of 1997. The state Health Department, in its annual report on the AIDS epidemic also predicted for the first time that the number of new AIDS...

Six of every thousand Alabama patients test HIV-positive.
August 24, 1992... A study of Alabama hospital patients found that black patients and men were more likely to be carriers of HIV. The study by the Alabama Department of Public Health found that 6.2 of every 1,000 patients admitted to Alabama hospitals...

Updated dental sterilization guidelines announced. (American Dental Association)
August 24, 1992... New concerns about AIDS recently prompted the American Dental Association to update its guidelines to prevent transmission of infectious diseases in the dental office. Among other things, the new guidelines direct dentists to...

Agency unveils public service spots against AIDS. (U.S. Department of Health and Human Services)
August 24, 1992... The government hopes a couple of cartoon characters woozily waking up from a night of drugs and anonymous sex will warn college-age people that one wild evening can lead to AIDS. "The `Get High, Get Stupid, Get AIDS' campaign fulfills...

Judge says doctor is liable for revealing patient's HIV status. (Dr. Sherry Rogers) (New York)
August 24, 1992... A Syracuse, New York, doctor says she thought she was obeying the law when she turned over medical records revealing to her patient's employer that he had HIV. However, a judge ruled she was violating New York's public health law. ...

Woman injected with HIV-infected needle settles lawsuit. (California)
August 24, 1992... A woman injected with a syringe that had been used on an AIDS patient in a hospital mix-up in 1990 has settled her lawsuit against the hospital for $1 million. The amount of the settlement wasn't made public but appeared in documents...

AIDS patient testing of potential AIDS therapy begins. (Oxandrin, oxandrolone for muscle weakness) (Gynex Pharmaceuticals Inc.)
August 24, 1992... Gynex Pharmaceuticals Inc., Vernon Hills, Illinois, announced it has begun a multicenter, placebo-controlled clinical study of its drug Oxandrin (oxandrolone) for the treatment of AIDS patients suffering from HIV-associated muscle weakness....

Approval received to advance all patients to full-strength drug in AIDS treatment trial. (Passive Hyperimmune Therapy) (HemaCare Corp.)
August 24, 1992... HemaCare Corp., Los Angeles, California, announced that based on the results obtained from an interim, six-month analysis of its trial of Passive Hyperimmune Therapy (PHT) in the treatment of AIDS, it has, with approval from the California...

Issuance of antisense patent announced. (Isis Pharmaceuticals Inc.)
August 24, 1992... Isis Pharmaceuticals Inc., Carlsbad, California, announced issuance of a patent covering novel oligonucleotides. The patent covers a new class of oligonucleotides created by the attachment of various polyamines. Such oligonucleotides...

Bloodborne Pathogens Standard video training programs available for healthcare workers and emergency responders. (SAVANT Audiovisuals Inc.)
August 24, 1992... Two new video training programs that cover compliance with the mandatory training requirements of the Bloodborne Pathogens (BBP) Standard are now available from SAVANT Audiovisuals Inc. The new BBP law covers millions of workers in...

HIV infection within networks of prostitute women and injecting drug users. (Research Report)
August 24, 1992... AUTHORS: S.Q. Muth, D.E. Woodhouse, J.J. Potterat, J.B. Muth and W.W. Darrow. El Paso County Health Department, Colorado Springs, Colorado, and U.S. Centers for Disease Control, Atlanta, Georgia. According to an abstract submitted by...

HIV prevalence among attenders of a clinic for STD: the potential risk of heterosexual transmission in Amsterdam. (sexually transmitted diseases) (Research Report)
August 24, 1992... AUTHORS: H.S.A. Fennema, E.J.C. van Ameijden, R.A. Coutinho, G.J.J. van Doornum, C. Henquet and J.A.R. van dan Hoek. Municipal Health Service, Amsterdam, the Netherlands. According to an abstract submitted by the authors to the VIII...

HIV infection in long distance truck drivers in Kenya: seroprevalence, seroincidence and risk factors. (Research Report)
August 24, 1992... AUTHORS: J. Bwayo, M.A. Omari, A.N. Mutere, F.A. Plummer, S. Moses, J.O. Ndinya-Achola and J.K. Kreiss. University of Nairobi, Nairobi, Kenya; University of Manitoba, Winnipeg, Canada; University of Washington, Seattle, Washington. ...

The effect of partner mixing and migration on the spread of gonorrhea, chlamydia and HIV, a model study. (Research Report)
August 24, 1992... AUTHORS: H. Stigum, W. Falck( 1), P. Mangus and L.S. Bakketeig. Department of Epidemiology, National Institute of Public Health, Oslo, Norway; (1)Division of Zoology, Department of Biology, University of Oslo, Oslo, Norway. According...

A network-informed strategy for preventing HIV among street gang members. (Research Report)
August 24, 1992... AUTHORS: J. Potterat, P. Bethea, S. Muth, D. Woodhouse and J. Muth. El Paso County Department of Health and Environment, Colorado Springs, Colorado. According to an abstract submitted by the authors to the VIII International...

Detection of a human intracisternal retroviral particle associated with CD4+ T-cell deficiency. (idiopathic CD4+ T-lymphocytopenia) (Periodical Report)
August 24, 1992... SOURCE: Proceedings of the National Academy of Sciences, August 15, 1992;89(16) A California research team reports evidence of retrovirus-like particles and reverse transcriptase activity in an HIV-negative 66-year-old woman with...

Progressive increases in serum catalase activity in advancing human immunodeficiency virus infection. (Periodical Report)
August 24, 1992... SOURCE: Free Radical Biology and Medicine, August 1992;13(2):143-149. People with AIDS have elevated serum levels of catalase activity, University of Colorado researchers report. Researchers J.A. Leff of the University of...

Interface of malnutrition and human immunodeficiency virus infection in Sub-Saharan Africa - a critical review. (Periodical Report)
August 24, 1992... SOURCE: Nutrition Research, August 1992;12:(8):1041-1050. Malnutrition exacerbates the impact of AIDS on Africa, a nutritionist argues. C.O. Enwonwu of Meharry Medical College, Nashville, Tennessee, notes that the World Health...

Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. (Periodical Report)
August 24, 1992... SOURCE: Proceedings of the National Academy of Sciences, July 15, 1992;89:(14):6265-6269. A new, short oligodeoxynucleotide analog that appears to have multiple anti-HIV effects has great potential as an AIDS therapeutic. ...

Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages - in vitro and in vivo studies. (Periodical Report)
August 24, 1992... SOURCE: Proceedings of the National Academy of Sciences, July 15, 1992;89(14):6477-6481. Italian scientists describe an ingenious method for targeting antiretroviral nucleoside analogs to macrophages. University of Urbino...

AIDS-like illness rare, government researchers say. (U.S. Centers for Disease Control)
August 17, 1992... U.S. CDC Nine new cases of a puzzling AIDS-like illness have been identified in the United States, but the condition still appears to be extremely rare, U.S. health officials said August 6, 1992 (Department Periodical Report, this...

HIV, mycoplasmal superantigens program T cells for death, Montagnier says. (Luc Montagnier's theory of AIDS cofactors) (VIII International Conference on AIDS)
August 17, 1992... VIII International Conference on AIDS HIV discoverer Luc Montagnier reasserted his controversial theory that mycoplasma act as cofactors in AIDS pathogenesis at the opening session of the VIII International Conference on AIDS in...

Group focuses on development of worldwide registry of HIV clinical trials. (Core Working Group for the Development of an International Registry of HIV Clinical Trials) (VIII International Conference on AIDS)
August 17, 1992... VIII International Conference on AIDS A core working group was formed at the VIII International Conference on AIDS to determine the future of a potential international registry of HIV clinical trials. No single compiled source of...

Company official offers additional information on news brief. (Sarah Martin-Munley; Foscavir injection therapy) (Astra Pharmaceutical Products)
August 17, 1992... Astra Pharmaceutical Products AIDS Weekly reported in its July 27, 1992, issue, page 20, that two AIDS activist groups announced a U.S. boycott of products manufactured by Astra Pharmaceuticals Products Inc, Westborough, Massachusetts....

Three hospital patients mistakenly injected with HIV. (U.S. Centers for Disease Control)
August 17, 1992... U.S. CDC A San Diego hospital patient and at least two others elsewhere were injected with HIV because of sloppy work by employees who didn't follow basic precautions the U.S. Centers for Disease Control (CDC) said. The...

Two people infected with SIV spurs investigation. (laboratory researchers accidentally acquired simian immunodeficiency virus) (U.S. National Institutes of Health)
August 17, 1992... U.S. NIH Two laboratory researchers were infected with simian immunodeficiency virus (SIV) but did not develop symptoms of an immune disorder, the U.S. National Institutes of Health (NIH) said. The NIH and the U.S. Centers for...

AIDS program to test Procysteine. (Brown University)
August 17, 1992... Brown University The Brown University AIDS Program, Providence, Rhode Island, will participate in the first human trials of Procysteine, a drug that could slow the spread of AIDS and reduce symptoms of the virus. The Brown program...

Immunoglobulin holds off some infections in HIV-infected children. (U.S. National Institute of Child Health and Human Development)
August 17, 1992... U.S. NICHD Monthly injections of immunoglobulin may help some HIV-infected children fight viral and minor bacterial infections, according to a study published in the July 22, 1992, issue of the Journal of the American Medical...

Scientists speed up enzyme evolution in lab. (Scripps Research Institute)
August 17, 1992... Scripps Research Institute Scripps Research Institute, La Jolla, California, scientists have hastened and directed the evolution of a molecule in a test tube - a new process that someday might help fight viral diseases such as AIDS. ...

TLC G-65 Phase III trials started in Europe. (new drug for Mycobacterium avium-intracellulare infection) (United Kingdom)
August 17, 1992... United Kingdom TLC G-65, a new drug for the most common systemic bacterial infection afflicting AIDS patients, Mycobacterium avium-intracellulare (MAI), has entered a Phase III clinical trial in Europe, the Liposome Company Inc.,...

Epitope's OraSure device receives approval. (oral specimen collection device) (Mexico)
August 17, 1992... Mexico Epitope Inc., Beaverton, Oregon, announced that the Secretary of Health of Mexico has approved commercial distribution of the company's OraSure oral specimen collection device. The action follows the successful completion...

Rapid assay for the detection of tuberculosis announced. (using DNA-probe technology & polymerase chain reaction) (SmithKline Beecham)
August 17, 1992... SmithKline Beecham SmithKline Beecham Clinical Laboratories Inc. (SBCL), King of Prussia, Pennsylvania, announced it will introduce a new assay for the detection of the organism that causes the most common forms of tuberculosis. ...

Ex-Soviets risk HIV epidemic. (Russia)
August 17, 1992... Russia Changes in Russia since the fall of communism will contribute to a drastic increase in AIDS cases, an expert on the disease says. "This is a society where the pill is not used, abortion is still the main method of birth...

Movie version of Randy Shilts' "And the Band Played On" in pre-production. (HBO Pictures) (Atlanta, San Francisco)
August 17, 1992... Atlanta, San Francisco HBO Pictures announced on August 10, 1992, that it will produce a movie based on "And the Band Played On," by Randy Shilts, with filming to begin this fall. Filming of the movie version of the best-selling...

AIDS Weekly and AIDS Therapies among 11 new titles added to full-text Newsletter Database. (Predicasts)
August 17, 1992... Predicasts Predicasts, Cleveland, Ohio, has enhanced its coverage of medicine and healthcare with the addition of 11 new full-text titles in the Newsletter Database, available on Dialog, Data-Star and Dow Jones News/Retrieval. ...

Journal of Pharmaceutical Care in AIDS/HIV Treatment announced. (Haworth Press Inc.)
August 17, 1992... Haworth Press Inc. Pharmaceutical Products Press, an imprint of Haworth Press Inc., announced the forthcoming publication of the new Journal of Pharmaceutical Care in AIDS/HIV Treatment. The editor of this new journal is Roberta...

Neuro-AIDS: HIV-1 infection and the nervous system. (National Institute of Neurological Disorders and Stroke, National Institute of Mental Health research grant announcement) (Research Report)
August 17, 1992... AUTHORS: PA Number: PA-92-95. National Institute of Neurological Disorders and Stroke, National Institute of Mental Health. "Purpose: The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of...

Analysis of the zinc-fingerlike domains in the HIV-1 nucleocapsid protein by alanine scanning mutagenesis. (Research Report)
August 17, 1992... AUTHORS: T. Dorfman, J. Luban, S. Godd and W. Haseltine. Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, and Columbia University, New York, New York. According to an abstract submitted by the authors to...

Functional study of HIV-1 matrix proteins in virus assembly and infectivity. (Research Report)
August 17, 1992... AUTHORS: X. Yu, X. Yuan, T.H. Lee and M. Essex. Harvard School of Public Health, Boston, Massachusetts. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the...

Assembly of HIV-1 gag protein: a new target for antiviral therapy? (Research Report)
August 17, 1992... AUTHORS: M. Neidrig, H. Gelderblom, G. Pauli, J. Marx, A. v.Poblotzki, H. Wolf and S. Modrow. Behringwerke AG, Research Department, Marburg, Germany; Robert-Koch-Institut and AIDS-Zentrum des BGA, Berlin, Germany; Max von...

Production of chimeric virus-like particles containing the HIV-1 gag/pol and HIV-2 gag gene productions. (Research Report)
August 17, 1992... AUTHORS: M. Kawamura, T. Shioda, T. Kitamura, Y. Iwakua and H. Shivuta. Japanese Foundation of AIDS Prevention; Department of Viral Infection, Institute of Medical Science, University of Tokyo; National Institute of Health, Japan. ...

Ganciclovir (GCV) and granulocyte-macrophage colony stimulating factor (GM-CSF) vs. GCV alone as treatment for cytomegalovirus (CMV) retinitis (ACTG 073). (Research Report)
August 17, 1992... AUTHORS: D. Hardy, S. Spector, B. Polsky, C. Crumpacker, C. van der Horst, G. Holland, W. Freeman, M.-H. Heinemann, G. Sharuk, J. Klystra and M. Chown. University of California, Los Angeles, Los Angeles, California; University of...

Recombinant granulocyte-colony stimulating factor (rG-CSF) in the treatment of neutropenic AIDS patients. (Research Report)
August 17, 1992... AUTHORS: J. Fuhrer, M. Shelton and H. Heller. State University of New York at Stony Brook, New York. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the Netherlands,...

Specific enhancement of anti-HIV immunotoxin activity by addition of soluble CD4. (Research Report)
August 17, 1992... AUTHORS: S.H. Pincus. NIAID Rocky Mountain Laboratories, Hamilton, Montana. According to an abstract presented to the Third International Symposium on Immunotoxins, held June 19-21, 1992, in Orlando, Florida, "We have constructed a...